Issued Patents All Time
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11925629 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Sanjeeva P. Reddy, Raghava Reddy Kethiri +2 more | 2024-03-12 |
| 11352322 | Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors | Sridharan Rajagopal, Mahanandeesha S. HALLUR, Purushottam Dewang, Kannan Murugan, Durga Prasanna Kumar C. H. +7 more | 2022-06-07 |
| 11319326 | Tricyclic fused derivatives of 1-(cyclo)alkyl pyrtdin-2-one useful for the treatment of cancer | Saravanan Vadivelu, Sridharan Rajagopal, Murugan CHINNAPATTU, Pavan Kumar Gondrala, Dhanalakshmi Sivanandhan | 2022-05-03 |
| 11267820 | Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors | Saravanan Vadivelu, Sridharan Rajagopal, Manjunatha M. Ramaiah, Pavan Kumar Gondrala, Murugan CHINNAPATTU +2 more | 2022-03-08 |
| 11103491 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Sanjeeva P. Reddy, Raghava Reddy Kethiri +2 more | 2021-08-31 |
| 10751332 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Sanjeeva P. Reddy, Raghava Reddy Kethiri +2 more | 2020-08-25 |
| 10689390 | Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer | Saravanan Vadivelu, Sridharan Rajagopal, Murugan CHINNAPATTU, Pavan Kumar Gondrala, Dhanalakshmi Sivanandhan | 2020-06-23 |
| 10689395 | Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors | Saravanan Vadivelu, Sridharan Rajagopal, Manjunatha M. Ramaiah, Pavan Kumar Gondrala, Murugan CHINNAPATTU +2 more | 2020-06-23 |
| 10471051 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Sanjeeva P. Reddy, Raghava Reddy Kethiri +4 more | 2019-11-12 |
| 9896445 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Aranapakam Venkatesan, Scott K. Thompson, Roger Smith, Sanjeeva P. Reddy, Raghava Reddy Kethiri +4 more | 2018-02-20 |